Pages
IT equipment amnesty - we need your help please!
IT equipment amnesty - we need your help please!
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/it-equipment-amnesty
World AIDS Day reminds us of importance of early testing
https://dchs.nhs.uk/news/world-aids-day-reminds-us-importance-early-testing
October is AAC Awareness Month!
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/october-aac-awareness-month
Thanks to John Briggs for 50 years of NHS volunteering
https://dchs.nhs.uk/news/thanks-john-briggs-50-years-nhs-volunteering
Inadine – alert on its usage
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/inadine-alert-its-usage
Private Alice Bell marching into history
https://dchs.nhs.uk/news/dchs-staff-marching-coronation-parade
Contractor appointed to build new £15m health services hub for Belper
https://dchs.nhs.uk/news/contractor-appointed-build-new-15m-health-services-hub-belper
Files
L277 - Degenerative Cervical Myelopathy
L277 - Degenerative Cervical Myelopathy Warning Card
Moisture Associated Skin Damage Barrier Film Pathway (G197)
Moisture Associated Skin Damage Barrier Film Pathway including MEDI DERMA-S Instructions for Use Guide
1060 - Anticipatory Medication (s.c.) Administration Chart and Stock Balance Sheet
1060 - Anticipatory Medication (s.c.) Administration Chart and Stock Balance Sheet
L29 - UTC Advice leaflet - Why an X-Ray may not be indicated
L29 - UTC Advice leaflet - Why an X-Ray may not be indicated
Identification and Treatment of Different Types of Moisture Lesions (G179)
A moisture lesion is most commonly associated with either incontinence or sweating between skin folds. If left untreated then skin is more at risk of pressure ulcer development. It is important to establish the cause of the moisture lesion in order to treat it correctly.
Informal Carers administration of PRN subcutaneous injection in Community Palliative care Guidelines for DCHS staff (G184)
A small number of dying patients’ relatives request permission to administer subcutaneous medication at home to enable symptom control. UK statutory law supports this practice within a safe governance structure. To support this in practice “The Derbyshire policy for Informal Carers Administration of an as required subcutaneous injection in Community Palliative care” has been developed and underpins these guidelines for Derbyshire Community Health Service (DCHS) staff.
Disconnection of Continuous Infusional Chemotherapy from a Central Venous Access Device (CVAD) in the Community SOP (S65)
The aim of this SOP is to provide guidance for staff in the clinical procedure of the disconnection of continuous infusion chemotherapy from a CVAD within a DCHS setting across adult services. This SOP is intended to reduce the level of risks associated with this procedure.
Was Not Brought - Did Not Attend - No Access Visit Policy (P88)
The purpose of this document is to outline the responsibilities of Derbyshire Community Health Services NHS Foundation Trust (DCHS) staff when parents/carers disengage from health services and there are concerns about the welfare of children and adults in their care. Laming (2003) and learning from serious case reviews and safeguarding adult reviews show that disengagement from healthcare may be partial, intermittent, persistent or terminal in nature. It is widely acknowledged that ‘was not brought’/‘non-attendance’ and avoidance of seeing health staff can be a sign that things are not as they should be within the family and/or person’s life. This may have serious consequences for some children and adults dependent on others to meet their care and support needs. It may also signal potential abuse or neglect. It is imperative that early non engagement with services is identified in order for health practitioners to consider if this is a safeguarding concern that requires a safeguarding referral, safety planning or escalation.
NHSImprovement-G6Self-CertificationMay21.pdf
NHS Improvement-G6Self-Certification May21
Mileage consultation frequently asked questions - v2
DCHS mileage consultation FAQs v2